Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
2017 · Nature Communications · 569 citations
https://doi.org/10.1038/s41467-017-01968-5
J
Jingsong Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
340
Papers
6.3K
Citations
33
h-index
78
i10-index
Jingsong Zhang is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers. The author has an h-index of 33, co-authored 289 publications.
ORCID: 0000-0003-1192-5116Papers by this author
worksAtaxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
2019 · Journal of Hematology & Oncology · 146 citations
https://doi.org/10.1186/s13045-019-0733-6
Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
2020 · Nature Communications · 103 citations
https://doi.org/10.1038/s41467-020-15424-4
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
2023 · European Urology · 84 citations
https://doi.org/10.1016/j.eururo.2023.05.021
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non–muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin
2020 · European Urology · 47 citations
https://doi.org/10.1016/j.eururo.2020.02.012
Preliminary results from a phase 1/2 study of co-stimulatory bispecific PSMAxCD28 antibody REGN5678 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
2023 · Journal of Clinical Oncology · 27 citations
https://doi.org/10.1200/jco.2023.41.6_suppl.154
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat